NorthWest Biotherapeutics Inc (NWBO)

[Gus1212]

Finally - but not much here

News coverage about Northwest Biotherapeutics (NASDAQ:NWBO) has trended positive recently, Accern reports. The research firm identifies negative and positive press coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Northwest Biotherapeutics earned a coverage optimism score of 0.43 on Accern’s scale. Accern also gave press coverage about the biotechnology company an impact score of 75 out of 100, meaning that recent press coverage is likely to have an impact on the stock’s share price in the next few days.

Northwest Biotherapeutics (NWBO) opened at 0.255 on Friday. The company has a 50-day moving average of $0.17 and a 200 day moving average of $0.30. The stock’s market capitalization is $48.91 million. Northwest Biotherapeutics has a 12 month low of $0.14 and a 12 month high of $0.98.